FGFR1 and neoplasm: Furthermore, combined inhibition of FGFR1 and CDK4/6 in CAMA1 cell line abolished anti-estrogen resistance suggesting that an interaction between FGFR1 and cyclin D1 might drive estrogen-independent proliferation in co-amplified tumours [107].